Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 4, 2022

Primary Completion Date

December 3, 2024

Study Completion Date

December 3, 2024

Conditions
Intracranial Hemorrhages
Interventions
DRUG

Colchicine Pill

Anti-inflammatory

OTHER

Placebo

Inert ingredients

Trial Locations (11)

Unknown

University of Calgary, Foothills Medical Centre, Calgary

University of Alberta, Edmonton

University of British Columbia, Vancouver

Kingston General Hospital, Kingston Health Sciences, Kingston

London Health Science Centre, University Hospital, London

Ottawa Hospital Research Institute, Ottawa

Sunnybrook Hospital, Toronto

Toronto Western Hospital, Toronto

University of Montreal, Montreal

University of Saskatchewan, Saskatoon

L8L 2X2

Hamilton General Hospital, Hamilton Health Sciences, Hamilton

All Listed Sponsors
lead

Population Health Research Institute

OTHER

NCT05159219 - Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage | Biotech Hunter | Biotech Hunter